Scott Gottlieb steps down from US FDA leadership

被引：0

作者：

Jaffe, Susan

机构：

来源：

LANCET | 2019年 / 393卷 / 10176期

关键词：

D O I：

10.1016/S0140-6736(19)30575-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：1086 / 1087

页数：2

相关论文

共 50 条

[31] Letter From the Commissioner’s Office at the US FDA
John A. Vernon
PharmacoEconomics, 2007, 25 : 89 - 90
[32] Letter From the Commissioner’s Office at the US FDA
John A. Vernon
PharmacoEconomics, 2006, 24 : 1179 - 1179
[33] Letter from the Commissioner's Office at the US FDA
Vernon, John A.
PHARMACOECONOMICS, 2007, 25 (02) : 89 - 90
[34] Letter From the Commissioner’s Office at the US FDA
John A. Vernon
PharmacoEconomics, 2007, 25 : 267 - 268
[35] Letter From the Commissioner’s Office at the US FDA
John A. Vernon
PharmacoEconomics, 2007, 25 : 1 - 2
[36] FDA requests withdrawal of lorcaserin from US market
Reactions Weekly, 2020, 1792 (1) : 1 - 1
[37] Qnexa gets thumbs down from FDA safety panel
Reactions Weekly, 2010, 1311 (1) : 6 - 6
[38] Down from the Pedestal The Influence of Anne Scott's Southern Ladies
Edwards, Laura F.
WRITING WOMEN'S HISTORY: A TRIBUTE TO ANNE FIROR SCOTT, 2011, : 28 - 63
[39] Transformational leadership: Lessons from US experience
Dess, GG
Picken, JC
Lyon, DW
LONG RANGE PLANNING, 1998, 31 (05) : 722 - 731
[40] Accelerated approval of Iressa from FDA news releases (FDA US Food and Drug Administration)
Shimada, Y
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2003, 33 (07) : 369 - 369

← 1 2 3 4 5 →